4. Summary of evidence quality.
Foreit 1993 | Hardy 1998 | Nacar 2003 | Abdel‐Tawab 2008 | Lee 2011 | Sebastian 2012 | |
NOS criteria for cohort studies | ||||||
Exposed cohort representativeness | ‐‐‐ | ‐‐‐ | ‐‐‐ | ‐‐‐ | ‐‐‐ | ‐‐‐ |
Nonexposed cohort selection | ✸ | ‐‐‐ | ✸ | ‐‐‐ | ✸ | ‐‐‐ |
Exposure ascertainment: method used | ✸ | ‐‐‐ | ✸ | ✸ | ✸ | ✸ |
Comparability of groups: design or analysis | ‐‐‐ | ✸✸ | ‐‐‐ | ✸ | ‐‐‐ | ✸✸ |
Outcome assessment: method used | ‐‐‐ | ‐‐‐ | ‐‐‐ | ‐‐‐ | ‐‐‐ | ‐‐‐ |
Follow‐up length | ✸ | ✸ | ✸ | ✸ | ✸ | ✸ |
Follow‐up adequacy | ‐‐‐ | ‐‐‐ | ✸ | ✸ | ‐‐‐ | ‐‐‐ |
Intervention fidelity (>= 4 criteria) | ‐‐‐ | ‐‐‐ | ‐‐‐ | ✸ | ‐‐‐ | ✸ |
Quality of evidence1,2 | Poor | Very low | Very low | Low | Poor | Low |
1Evidence was initially considered moderate quality and then downgraded for 1) no stars for comparability (not controlling for confounding), 2) not meeting >= 4 of remaining 6 NOS criteria, and 3) not having intervention fidelity information for >= 4 categories. Quality grades were moderate, low, very low, or poor. 2We did not use criterion for 'outcome of interest not present at study start' (Assessment of risk of bias in included studies).